Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation

Acute pancreatitis (AP) is a common and serious acute inflammatory disease with high severity rate and mortality. Inflammation and oxidative stress play an extremely important role in the development of AP disease. Polyvinylpyrrolidone‐modified iridium nanoparticles (IrNP‐PVP) have multienzyme mimet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biomedical materials research. Part A 2024-07, Vol.112 (7), p.988-1003
Hauptverfasser: Jin, Wenzhang, Xie, Xueting, Shen, Shuqi, Zhou, Xingjian, Wang, Shunfu, Zhang, Lijiang, Su, Xiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1003
container_issue 7
container_start_page 988
container_title Journal of biomedical materials research. Part A
container_volume 112
creator Jin, Wenzhang
Xie, Xueting
Shen, Shuqi
Zhou, Xingjian
Wang, Shunfu
Zhang, Lijiang
Su, Xiang
description Acute pancreatitis (AP) is a common and serious acute inflammatory disease with high severity rate and mortality. Inflammation and oxidative stress play an extremely important role in the development of AP disease. Polyvinylpyrrolidone‐modified iridium nanoparticles (IrNP‐PVP) have multienzyme mimetic activity, and the aim of this article is to discuss the therapeutic alleviative effects of the ultrasmall nanozymes IrNP‐PVP on AP through their antioxidant and anti‐inflammatory effects. IrNP‐PVP were proved to inhibit inflammation and scavenge reactive oxygen species (ROS) at the cellular level. The synthetic IrNP‐PVP exhibit remarkable antioxidant and anti‐inflammatory activities in the prevention and treatment of AP mice by establishing murine AP model, which can reduce the oxidative stress and inflammatory response. The results of this article indicated that the ultrasmall nanozymes IrNP‐PVP effectively alleviate AP via scavenging ROS as well as suppressing inflammation both in vivo and in vitro, which might provide enormous promise for the AP management.
doi_str_mv 10.1002/jbm.a.37679
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2922951035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2922951035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3559-44390272830831a74c4a8151b8aba84c0e6d1431e0d4cab4e2f4f0a5060472d93</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSMEoqWwYo8isUFCufg3N162Fb8qYkPX1iR2xFw5drCdW7LjEdjwgjwJvr2FBQtWZ470zdGMTlU9pWRDCWGvdv20gQ3ftlt1rzqlUrJGqFbeP8xCNZyp9qR6lNKuwC2R7GF1wjtOO8XEafXz2uUIaQLn6jm4dY9-dfMaY3Bogre_vv-YgsERrakxosFlqj34MEPMODib6hvMX2rwGcM3NEXLbG59WUU_OpgmyCGuNQwZ95jXegyxmCXbegY_RAsZM6a6nGD3WEzwj6sHI7hkn9zpWXX95vXny3fN1ae37y_Pr5qBS6kaIbgibMs6TspDsBWDgI5K2nfQQycGYltDBaeWGDFALywbxUhAkpaILTOKn1UvjrlzDF8Xm7KeMA3WOfA2LEkzxZiSlHBZ0Of_oLuwRF-u05yIAkkqDtTLIzXEkFK0o54jThBXTYk-tKVLWxr0bVuFfnaXufSTNX_ZP_UUgB2BG3R2_V-W_nDx8fyY-huWGqYE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3049515145</pqid></control><display><type>article</type><title>Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation</title><source>MEDLINE</source><source>Wiley Online Library (Online service)</source><creator>Jin, Wenzhang ; Xie, Xueting ; Shen, Shuqi ; Zhou, Xingjian ; Wang, Shunfu ; Zhang, Lijiang ; Su, Xiang</creator><creatorcontrib>Jin, Wenzhang ; Xie, Xueting ; Shen, Shuqi ; Zhou, Xingjian ; Wang, Shunfu ; Zhang, Lijiang ; Su, Xiang</creatorcontrib><description>Acute pancreatitis (AP) is a common and serious acute inflammatory disease with high severity rate and mortality. Inflammation and oxidative stress play an extremely important role in the development of AP disease. Polyvinylpyrrolidone‐modified iridium nanoparticles (IrNP‐PVP) have multienzyme mimetic activity, and the aim of this article is to discuss the therapeutic alleviative effects of the ultrasmall nanozymes IrNP‐PVP on AP through their antioxidant and anti‐inflammatory effects. IrNP‐PVP were proved to inhibit inflammation and scavenge reactive oxygen species (ROS) at the cellular level. The synthetic IrNP‐PVP exhibit remarkable antioxidant and anti‐inflammatory activities in the prevention and treatment of AP mice by establishing murine AP model, which can reduce the oxidative stress and inflammatory response. The results of this article indicated that the ultrasmall nanozymes IrNP‐PVP effectively alleviate AP via scavenging ROS as well as suppressing inflammation both in vivo and in vitro, which might provide enormous promise for the AP management.</description><identifier>ISSN: 1549-3296</identifier><identifier>ISSN: 1552-4965</identifier><identifier>EISSN: 1552-4965</identifier><identifier>DOI: 10.1002/jbm.a.37679</identifier><identifier>PMID: 38318924</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Acute Disease ; acute pancreatitis ; Animals ; Anti-inflammatory agents ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Antioxidants ; Antioxidants - chemistry ; Antioxidants - pharmacology ; inflammation ; Inflammatory diseases ; Inflammatory response ; Iridium ; Iridium - chemistry ; Iridium - pharmacology ; iridium nanoparticles ; Male ; Metal Nanoparticles - chemistry ; Metal Nanoparticles - therapeutic use ; Mice ; Nanoparticles ; Oxidative stress ; Oxidative Stress - drug effects ; Pancreatitis ; Pancreatitis - drug therapy ; Polyvinylpyrrolidone ; Povidone - chemistry ; Povidone - pharmacology ; RAW 264.7 Cells ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Scavenging</subject><ispartof>Journal of biomedical materials research. Part A, 2024-07, Vol.112 (7), p.988-1003</ispartof><rights>2024 The Authors. published by Wiley Periodicals LLC.</rights><rights>2024 The Authors. Journal of Biomedical Materials Research Part A published by Wiley Periodicals LLC.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3559-44390272830831a74c4a8151b8aba84c0e6d1431e0d4cab4e2f4f0a5060472d93</cites><orcidid>0000-0002-3251-5792</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjbm.a.37679$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjbm.a.37679$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38318924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jin, Wenzhang</creatorcontrib><creatorcontrib>Xie, Xueting</creatorcontrib><creatorcontrib>Shen, Shuqi</creatorcontrib><creatorcontrib>Zhou, Xingjian</creatorcontrib><creatorcontrib>Wang, Shunfu</creatorcontrib><creatorcontrib>Zhang, Lijiang</creatorcontrib><creatorcontrib>Su, Xiang</creatorcontrib><title>Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation</title><title>Journal of biomedical materials research. Part A</title><addtitle>J Biomed Mater Res A</addtitle><description>Acute pancreatitis (AP) is a common and serious acute inflammatory disease with high severity rate and mortality. Inflammation and oxidative stress play an extremely important role in the development of AP disease. Polyvinylpyrrolidone‐modified iridium nanoparticles (IrNP‐PVP) have multienzyme mimetic activity, and the aim of this article is to discuss the therapeutic alleviative effects of the ultrasmall nanozymes IrNP‐PVP on AP through their antioxidant and anti‐inflammatory effects. IrNP‐PVP were proved to inhibit inflammation and scavenge reactive oxygen species (ROS) at the cellular level. The synthetic IrNP‐PVP exhibit remarkable antioxidant and anti‐inflammatory activities in the prevention and treatment of AP mice by establishing murine AP model, which can reduce the oxidative stress and inflammatory response. The results of this article indicated that the ultrasmall nanozymes IrNP‐PVP effectively alleviate AP via scavenging ROS as well as suppressing inflammation both in vivo and in vitro, which might provide enormous promise for the AP management.</description><subject>Acute Disease</subject><subject>acute pancreatitis</subject><subject>Animals</subject><subject>Anti-inflammatory agents</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antioxidants</subject><subject>Antioxidants - chemistry</subject><subject>Antioxidants - pharmacology</subject><subject>inflammation</subject><subject>Inflammatory diseases</subject><subject>Inflammatory response</subject><subject>Iridium</subject><subject>Iridium - chemistry</subject><subject>Iridium - pharmacology</subject><subject>iridium nanoparticles</subject><subject>Male</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Metal Nanoparticles - therapeutic use</subject><subject>Mice</subject><subject>Nanoparticles</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Pancreatitis</subject><subject>Pancreatitis - drug therapy</subject><subject>Polyvinylpyrrolidone</subject><subject>Povidone - chemistry</subject><subject>Povidone - pharmacology</subject><subject>RAW 264.7 Cells</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Scavenging</subject><issn>1549-3296</issn><issn>1552-4965</issn><issn>1552-4965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhSMEoqWwYo8isUFCufg3N162Fb8qYkPX1iR2xFw5drCdW7LjEdjwgjwJvr2FBQtWZ470zdGMTlU9pWRDCWGvdv20gQ3ftlt1rzqlUrJGqFbeP8xCNZyp9qR6lNKuwC2R7GF1wjtOO8XEafXz2uUIaQLn6jm4dY9-dfMaY3Bogre_vv-YgsERrakxosFlqj34MEPMODib6hvMX2rwGcM3NEXLbG59WUU_OpgmyCGuNQwZ95jXegyxmCXbegY_RAsZM6a6nGD3WEzwj6sHI7hkn9zpWXX95vXny3fN1ae37y_Pr5qBS6kaIbgibMs6TspDsBWDgI5K2nfQQycGYltDBaeWGDFALywbxUhAkpaILTOKn1UvjrlzDF8Xm7KeMA3WOfA2LEkzxZiSlHBZ0Of_oLuwRF-u05yIAkkqDtTLIzXEkFK0o54jThBXTYk-tKVLWxr0bVuFfnaXufSTNX_ZP_UUgB2BG3R2_V-W_nDx8fyY-huWGqYE</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Jin, Wenzhang</creator><creator>Xie, Xueting</creator><creator>Shen, Shuqi</creator><creator>Zhou, Xingjian</creator><creator>Wang, Shunfu</creator><creator>Zhang, Lijiang</creator><creator>Su, Xiang</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3251-5792</orcidid></search><sort><creationdate>202407</creationdate><title>Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation</title><author>Jin, Wenzhang ; Xie, Xueting ; Shen, Shuqi ; Zhou, Xingjian ; Wang, Shunfu ; Zhang, Lijiang ; Su, Xiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3559-44390272830831a74c4a8151b8aba84c0e6d1431e0d4cab4e2f4f0a5060472d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute Disease</topic><topic>acute pancreatitis</topic><topic>Animals</topic><topic>Anti-inflammatory agents</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antioxidants</topic><topic>Antioxidants - chemistry</topic><topic>Antioxidants - pharmacology</topic><topic>inflammation</topic><topic>Inflammatory diseases</topic><topic>Inflammatory response</topic><topic>Iridium</topic><topic>Iridium - chemistry</topic><topic>Iridium - pharmacology</topic><topic>iridium nanoparticles</topic><topic>Male</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Metal Nanoparticles - therapeutic use</topic><topic>Mice</topic><topic>Nanoparticles</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Pancreatitis</topic><topic>Pancreatitis - drug therapy</topic><topic>Polyvinylpyrrolidone</topic><topic>Povidone - chemistry</topic><topic>Povidone - pharmacology</topic><topic>RAW 264.7 Cells</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Scavenging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Wenzhang</creatorcontrib><creatorcontrib>Xie, Xueting</creatorcontrib><creatorcontrib>Shen, Shuqi</creatorcontrib><creatorcontrib>Zhou, Xingjian</creatorcontrib><creatorcontrib>Wang, Shunfu</creatorcontrib><creatorcontrib>Zhang, Lijiang</creatorcontrib><creatorcontrib>Su, Xiang</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of biomedical materials research. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Wenzhang</au><au>Xie, Xueting</au><au>Shen, Shuqi</au><au>Zhou, Xingjian</au><au>Wang, Shunfu</au><au>Zhang, Lijiang</au><au>Su, Xiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation</atitle><jtitle>Journal of biomedical materials research. Part A</jtitle><addtitle>J Biomed Mater Res A</addtitle><date>2024-07</date><risdate>2024</risdate><volume>112</volume><issue>7</issue><spage>988</spage><epage>1003</epage><pages>988-1003</pages><issn>1549-3296</issn><issn>1552-4965</issn><eissn>1552-4965</eissn><abstract>Acute pancreatitis (AP) is a common and serious acute inflammatory disease with high severity rate and mortality. Inflammation and oxidative stress play an extremely important role in the development of AP disease. Polyvinylpyrrolidone‐modified iridium nanoparticles (IrNP‐PVP) have multienzyme mimetic activity, and the aim of this article is to discuss the therapeutic alleviative effects of the ultrasmall nanozymes IrNP‐PVP on AP through their antioxidant and anti‐inflammatory effects. IrNP‐PVP were proved to inhibit inflammation and scavenge reactive oxygen species (ROS) at the cellular level. The synthetic IrNP‐PVP exhibit remarkable antioxidant and anti‐inflammatory activities in the prevention and treatment of AP mice by establishing murine AP model, which can reduce the oxidative stress and inflammatory response. The results of this article indicated that the ultrasmall nanozymes IrNP‐PVP effectively alleviate AP via scavenging ROS as well as suppressing inflammation both in vivo and in vitro, which might provide enormous promise for the AP management.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38318924</pmid><doi>10.1002/jbm.a.37679</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-3251-5792</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1549-3296
ispartof Journal of biomedical materials research. Part A, 2024-07, Vol.112 (7), p.988-1003
issn 1549-3296
1552-4965
1552-4965
language eng
recordid cdi_proquest_miscellaneous_2922951035
source MEDLINE; Wiley Online Library (Online service)
subjects Acute Disease
acute pancreatitis
Animals
Anti-inflammatory agents
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Antioxidants
Antioxidants - chemistry
Antioxidants - pharmacology
inflammation
Inflammatory diseases
Inflammatory response
Iridium
Iridium - chemistry
Iridium - pharmacology
iridium nanoparticles
Male
Metal Nanoparticles - chemistry
Metal Nanoparticles - therapeutic use
Mice
Nanoparticles
Oxidative stress
Oxidative Stress - drug effects
Pancreatitis
Pancreatitis - drug therapy
Polyvinylpyrrolidone
Povidone - chemistry
Povidone - pharmacology
RAW 264.7 Cells
Reactive oxygen species
Reactive Oxygen Species - metabolism
Scavenging
title Ultrasmall polyvinylpyrrolidone‐modified iridium nanoparticles with antioxidant and anti‐inflammatory activity for acute pancreatitis alleviation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A46%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultrasmall%20polyvinylpyrrolidone%E2%80%90modified%20iridium%20nanoparticles%20with%20antioxidant%20and%20anti%E2%80%90inflammatory%20activity%20for%20acute%20pancreatitis%20alleviation&rft.jtitle=Journal%20of%20biomedical%20materials%20research.%20Part%20A&rft.au=Jin,%20Wenzhang&rft.date=2024-07&rft.volume=112&rft.issue=7&rft.spage=988&rft.epage=1003&rft.pages=988-1003&rft.issn=1549-3296&rft.eissn=1552-4965&rft_id=info:doi/10.1002/jbm.a.37679&rft_dat=%3Cproquest_cross%3E2922951035%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3049515145&rft_id=info:pmid/38318924&rfr_iscdi=true